Pharmafile Logo
Pharmafocus logo
Advanced Search

OTC

Showing 15 posts of 39 posts found.

Prescribing image

Print adverts’ prescribing info could be axed

March 3, 2014
Medical Communications MHRA, OTC, medicines, prescribing

The UK drugs regulator is proposing new rules that could see pharma update safety information for their medicines online, whilst …

News
Pfizer image

Pfizer expands in Poland

December 4, 2013
Sales and Marketing OTC, Pfizer, Poland, polocard, zf polpharma

Pfizer has bought the rights to one of Poland’s biggest OTC brands in a move which sees the US group …

News

Pharmstandard buys Singapore API firm to guarantee supply

August 16, 2013
Manufacturing and Production OTC, Pharmstandard, bever

Russia’s largest drug company Pharmstandard has agreed a $590 million deal to buy the Singapore-based supplier of active pharmaceutical ingredients …

News
J&J image

J&J says revived OTC brands are ‘winning the hearts of consumers’

July 19, 2013
Manufacturing and Production, Sales and Marketing Control, FDA, GDP, J&J, JJ, OTC

Johnson & Johnson doesn’t usually provide specific financials for its over-the-counter pharmaceuticals business, but did so for the first time …

News
novartis image

Novartis’ Nebraska OTC plant still troubles company

February 11, 2013
Manufacturing and Production Novartis, OTC

Novartis has been forced to recall various over-the-counter (OTC) medicines made at its plant in Lincoln, Nebraska, after discovering failures …

News

Lundbeck sells $100m portfolio

January 22, 2013
Sales and Marketing Lundbeck, OTC, Panhematin, Recordati

Italian pharma group Recordati has paid $80 million to Lundbeck for a portfolio of products primarily aimed at the US …

News
Nexium image

Pfizer pays $250m for OTC Nexium rights

August 14, 2012
Sales and Marketing AstraZeneca, EMA, FDA, Nexium, OTC, Pfizer

Pfizer will pay $250 million to AstraZeneca in order to gain the rights to sell an over-the-counter form of the …

News
J&J image

J&J expects consent decree to extend through ‘most of 2013’

July 30, 2012
Manufacturing and Production FDA, J&J, JJ, McNeil, OTC, recall

Johnson & Johnson has said it expects the production capacity issues affecting two plants covered by a consent decree with …

News

GSK sells off OTC products

March 16, 2012
Sales and Marketing GSK, OTC, Omega Pharma, Zantac

GlaxoSmithKline has shed more of its non-core consumer health OTC products in a £391 million sale, including a German manufacturing …

News
FDA picture

Prescription drugs could become OTC under FDA plans

March 12, 2012
Sales and Marketing COPD, FDA, OTC, prescribing

The FDA is considering new plans to make drugs for chronic conditions available over-the-counter. These drugs could include medicines for …

News

Novartis appoints Brian McNamara to division head of OTC business

March 1, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brian McNamara, Novartis, OTC

Novartis has appointed Brian McNamara to the position of division head of its OTC (Over-the-Counter) business with immediate effect. McNamara …

Appointment
Novartis building

Novartis recalls products as GMP issues close OTC facility

January 9, 2012
Manufacturing and Production FDA, Novartis, OTC

Novartis has revealed that it is temporarily shutting down a manufacturing facility in Nebraska, US, and recalling four products as …

News
GSK picture

GSK sells off over-the-counter brands

December 22, 2011
Sales and Marketing GSK, OTC

GlaxoSmithKline has offloaded a number of OTC consumer health brands in North America for £426 million in cash.  Flagged up …

News
Merck & Co

Merck pulls out of J&J consumer venture

September 29, 2011
Sales and Marketing J&J, JJ, Merc & Co, OTC

Merck & Co has exited a joint venture with J&J, selling its stake in the J&J/Merck Consumer Pharmaceuticals business to …

News

GlaxoSmithKline to drop Alli and other OTC products

April 15, 2011
Research and Development, Sales and Marketing Alli, GSK, OTC, Tyverb

GlaxoSmithKline is to sell off its weight loss drug Alli and other less profitable non-prescription drugs. GSK announced its decision …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026